ArticleClinical journal of gastroenterology2025
Cognitive and ataxic adverse events following entrectinib treatment in NTRK1 fusion gene-positive intrahepatic cholangiocarcinoma: a case report.
Kazuya Koyama et al.PubMed ↗Publisher ↗
No numbers read from the abstract.